The store will not work correctly when cookies are disabled.
1-(3,5-Dimethylphenyl)-6-methyl-1H-pyrazolo[4,3-c]pyridine-4-(5H)-one
ID: ALA4546070
PubChem CID: 155289557
Max Phase: Preclinical
Molecular Formula: C15H15N3O
Molecular Weight: 253.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(C)cc(-n2ncc3c(=O)[nH]c(C)cc32)c1
Standard InChI: InChI=1S/C15H15N3O/c1-9-4-10(2)6-12(5-9)18-14-7-11(3)17-15(19)13(14)8-16-18/h4-8H,1-3H3,(H,17,19)
Standard InChI Key: KQWMSLYWYPJHSI-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
13.2897 -24.9904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2897 -25.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9950 -26.2120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7002 -25.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9950 -24.5776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6994 -24.9847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3043 -24.4405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9737 -23.6970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1645 -23.7819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6213 -23.1755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8757 -22.3978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3299 -21.7906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5295 -21.9600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2779 -22.7419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8254 -23.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5826 -26.2172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4075 -26.2168 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5831 -21.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4791 -22.9144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 5 1 0
2 3 1 0
3 4 1 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 10 1 0
2 16 1 0
4 17 2 0
12 18 1 0
14 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 253.31 | Molecular Weight (Monoisotopic): 253.1215 | AlogP: 2.64 | #Rotatable Bonds: 1 |
Polar Surface Area: 50.68 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.83 | CX Basic pKa: ┄ | CX LogP: 2.56 | CX LogD: 2.56 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.72 | Np Likeness Score: -1.39 |
References
1. Kumar S, Gupta S, Abadi LF, Gaikwad S, Desai D, Bhutani KK, Kulkarni S, Singh IP.. (2019) Synthesis and in-vitro anti-HIV-1 evaluation of novel pyrazolo[4,3-c]pyridin-4-one derivatives., 183 [PMID:31557609] [10.1016/j.ejmech.2019.111714] |